- Home
- ZNTL vs ASPS Comparison
ZNTL vs ASPS Comparison
Compare ZNTL & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- ASPS
- Stock Information
- Founded
- ZNTL 2014
- ASPS 1999
- Country
- ZNTL United States
- ASPS Luxembourg
- Employees
- ZNTL N/A
- ASPS N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- ZNTL Health Care
- ASPS Consumer Discretionary
- Exchange
- ZNTL Nasdaq
- ASPS Nasdaq
- Market Cap
- ZNTL 105.8M
- ASPS 124.0M
- IPO Year
- ZNTL 2020
- ASPS N/A
- Fundamental
- Price
- ZNTL $1.49
- ASPS $11.21
- Analyst Decision
- ZNTL Buy
- ASPS
- Analyst Count
- ZNTL 7
- ASPS 0
- Target Price
- ZNTL $8.46
- ASPS N/A
- AVG Volume (30 Days)
- ZNTL 805.4K
- ASPS 12.7K
- Earning Date
- ZNTL 11-11-2025
- ASPS 10-23-2025
- Dividend Yield
- ZNTL N/A
- ASPS N/A
- EPS Growth
- ZNTL N/A
- ASPS N/A
- EPS
- ZNTL N/A
- ASPS N/A
- Revenue
- ZNTL $26,865,000.00
- ASPS $168,271,000.00
- Revenue This Year
- ZNTL N/A
- ASPS $38.29
- Revenue Next Year
- ZNTL N/A
- ASPS N/A
- P/E Ratio
- ZNTL N/A
- ASPS N/A
- Revenue Growth
- ZNTL N/A
- ASPS 12.96
- 52 Week Low
- ZNTL $1.01
- ASPS $3.46
- 52 Week High
- ZNTL $5.44
- ASPS $15.96
- Technical
- Relative Strength Index (RSI)
- ZNTL 43.18
- ASPS 49.59
- Support Level
- ZNTL $1.60
- ASPS $10.72
- Resistance Level
- ZNTL $2.02
- ASPS $11.88
- Average True Range (ATR)
- ZNTL 0.13
- ASPS 0.75
- MACD
- ZNTL -0.04
- ASPS -0.02
- Stochastic Oscillator
- ZNTL 5.36
- ASPS 26.20
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.